Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith/Pfizer

Polar one

Feb 18, 2019 04:59PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith/Pfizer

in response to

Zenith/Pfizer

Polar one

posted on Feb 18, 2019 05:22PM

I haven't seen any updates to the timeline since the intial news release back in November 2018 that projected trial initiation Q1 2019. I haven't seen anything on ClinicalTrials.gov yet.